Since previous work indicated that lactate could strengthen anti-tumor immunity by increasing CD8+ T cells in multiple tumor models [38, 39], more immunological assays were warranted to confirm the associations between SIRT6/UHRF1 and immune evasion in BLCA. Here, CD8A is linked to bladder transitional cell carcinoma.